Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82f96f476d23a7668947a83cdaefcc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4319fe3d827bd24add491d4ed90e7692 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
filingDate |
2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7df878ed28ec4035d83519851c3964a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_907f647b86f9230f07c800508df545c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7cb5de8913a2559c6024c3c4492df02 |
publicationDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9788539-B2 |
titleOfInvention |
Platelet protection solution having beta-galactosidase and sialidase inhibitors |
abstract |
The present invention relates to a platelet protection solution (PPS) having an amount of one or more β-galactosidase inhibitors with or without an amount of one or more sialidase inhibitors, and optionally one or more glycan-modifying agents; and one or more of PPS components that include a salt, a citrate source, a carbon source, or any combination thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541105-B2 |
priorityDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |